Ivolve Group Limited - Period Ending 2023-03-31

Ivolve Group Limited - Period Ending 2023-03-31


Ivolve Group Limited 12438191 true 2022-03-01 2023-03-31 2023-03-31 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true T M Davies N D Robinson true false 12438191 2022-03-01 2023-03-31 12438191 2023-03-31 12438191 bus:OrdinaryShareClass1 2023-03-31 12438191 core:ShareCapital 2023-03-31 12438191 core:CurrentFinancialInstruments 2023-03-31 12438191 bus:FRS102 2022-03-01 2023-03-31 12438191 bus:AuditExempt-NoAccountantsReport 2022-03-01 2023-03-31 12438191 bus:FullAccounts 2022-03-01 2023-03-31 12438191 bus:RegisteredOffice 2022-03-01 2023-03-31 12438191 bus:Director2 2022-03-01 2023-03-31 12438191 bus:Director5 2022-03-01 2023-03-31 12438191 bus:OrdinaryShareClass1 2022-03-01 2023-03-31 12438191 bus:EntityHasNeverTraded 2022-03-01 2023-03-31 12438191 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-03-31 12438191 1 2022-03-01 2023-03-31 12438191 countries:EnglandWales 2022-03-01 2023-03-31 12438191 2021-03-01 2022-02-28 12438191 2022-02-28 12438191 bus:OrdinaryShareClass1 2022-02-28 12438191 core:ShareCapital 2022-02-28 12438191 core:CurrentFinancialInstruments 2022-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12438191

Ivolve Group Limited

Annual Report and Unaudited Financial Statements

for the Period from 1 March 2022 to 31 March 2023

 

Ivolve Group Limited

Profit and Loss Account for the Period from 1 March 2022 to 31 March 2023

The company has not traded during the period. During this period, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Ivolve Group Limited

(Registration number: 12438191)
Balance Sheet as at 31 March 2023

Note

2023
£

2022
£

Current assets

 

Debtors

4

1

1

Capital and reserves

 

Called up share capital

5

1

1

Shareholders' funds

 

1

1

For the financial period ending 31 March 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 9 November 2023 and signed on its behalf by:
 


N D Robinson
Director

 

Ivolve Group Limited

Notes to the Unaudited Financial Statements for the Period from 1 March 2022 to 31 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Royal Court
Basil Close
Chesterfield
S41 7SL
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Name of parent of group

These financial statements are consolidated in the financial statements of Ivolve Care Holdings Limited.

The financial statements of Ivolve Care Holdings Limited may be obtained from Companies House.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was as follows:

1 March 2022 to 31 March 2023
 No.

Year ended 28 February 2022
 No.

Directors

2

2

 

Ivolve Group Limited

Notes to the Unaudited Financial Statements for the Period from 1 March 2022 to 31 March 2023

4

Debtors

2023
£

2022
£

Amounts owed by related parties

1

1

5

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary shares of £1 each

1

1

1

1

         

6

Parent and ultimate parent undertaking

The company's immediate parent is Ivolve Care Holdings Limited, incorporated in England and Wales.

 The ultimate parent is Specialist Healthcare Operations Limited, incorporated in the Isle of Man.

 There is considered to be no single controlling party.